Related Experiment Video
Updated: Aug 5, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Altered default mode network homogeneity in chronic insomnia disorder: modulation by modified suanzaoren decoction
Shubao Wei1, Leyi Zhang2, Xiuqiong Chen1
1Department of Rehabilitation Medicine, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Objective:
Chronic Insomnia Disorder (CID) is characterized by maladaptive self-referential thinking linked to default mode network (DMN) dysfunction. Network Homogeneity (NH), a measure of local functional integration within networks, may capture this dysregulation but remains underexplored in CID and its response to treatment, particularly herbal medicine.
Methods:
This study employed resting-state functional magnetic resonance imaging (fMRI) to investigate DMN NH in 82 patients with CID (52 treated with Modified Suanzaoren Decoction [MSZRD], 30 with Estazolam) and 65 matched healthy controls (HCs). NH was calculated for the DMN. Baseline differences, longitudinal treatment effects (mixed-effects model), and correlations with clinical scores were examined. A support vector machine (SVM) classifier used baseline NH features for diagnostic discrimination.
Results:
At baseline, CID patients exhibited widespread abnormal NH in DMN nodes, including the temporal lobes, precuneus, and orbitofrontal cortex (OFC), compared to HCs. Post-treatment, a significant time effect (increased NH) was found in the right inferior frontal orbital gyrus (IFOG) and right superior temporal gyrus (STG) across both groups. Crucially, a group-by-time interaction was identified in the right medial frontal orbital gyrus (MFOG), where NH increased after MSZRD but decreased after Estazolam. Baseline NH in temporal regions correlated positively with insomnia and anxiety severity. The SVM classifier achieved significant accuracy in distinguishing patients from HCs.
Conclusions:
CID is characterized by dysfunctional integration within the DMN. MSZRD and Estazolam demonstrate both convergent and divergent neuromodulatory effects, with MSZRD uniquely altering NH in a key prefrontal regulatory hub.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Antidepressant Drugs: MAOIs and Other Agents